Nasdaq
$10.33▲ 0.36%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $82.9MShares out 8.0M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
7- 10.1Pre-market26.10.01 22:17425Other#●●●#●●●
JATT II Acquisition Corp.
Talawar Therapeutics has appointed Dr. Mittie Doyle and Susannah Gray to its Board of Directors ahead of its business combination with JATT II Acquisition Corp. These appointments are intended to support the advancement of TALA-125 into clinical trials and strengthen the company's financial governance as it prepares to become a public entity.…more
$10.33+0.36%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 9.18After-hours26.09.19 08:26SCHEDULE 13D/AOwnership
JATT II Acquisition Corp.
JATT Ventures II L.P. and Someit Sidhu have entered into a joint filing agreement on September 18, 2026, regarding their Schedule 13D filings for JATT II Acquisition Corp. ordinary shares. This agreement confirms the joint reporting obligations of the involved parties concerning their equity holdings in the company.…more
$10.33+0.36%vs prev closeView filingShare - 9.16Overnight26.09.16 09:37SCHEDULE 13DOwnership
JATT II Acquisition Corp.
JATT Ventures II L.P. and Someit Sidhu entered into a joint filing agreement on September 15, 2026, to file a Schedule 13D regarding the ordinary shares of JATT II Acquisition Corp. This agreement formalizes the joint reporting of their share ownership in the company.…more
$10.33+0.36%vs prev closeView filingShare
6 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 8.27Regular26.08.28 04:16#●●●#●●●
JATT III Acquisition Corp Completes $69 Million IPO
JATT III Acquisition Corp has successfully closed its $69 million initial public offering and is now trading on the Nasdaq. The company is a blank check entity focused on pursuing business combinations within the biotechnology and life sciences sectors.…more
$10.33+0.36%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 8.26Overnight26.08.26 15:47
●●●●●●●● ●●●●● ●●●●●●
Healthcare-focused SPAC JATT III Acquisition Corp has priced its initial public offering of 6 million shares at $10.00 per share, raising $60 million. The company will use the proceeds to pursue a business combination with a target in the healthcare sector.…more
$10.33+0.36%vs prev closeShareBenzinga - 8.25After-hours26.08.26 08:00
●●●●●●●● ●●●●● ●●●●●●
SPAC JATT III Acquisition Corp has priced its initial public offering at $60 million. The company intends to use the proceeds to pursue a business combination, primarily targeting the biotechnology and life sciences sectors.…more
$10.33+0.36%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report